Surgery for rheumatic tricuspid valve disease: A 30-year experience

Slides:

Advertisements

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Stephen R. Broderick, MD, MPHS

Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period Hector Alonso-Valle, MD, PhD, Concepcion Fariñas-Álvarez,

Outcome of 200 patients after an extracardiac Fontan procedure

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Surgical treatment of pseudoaneurysm of the thoracic aorta

Improving health care by embracing Systems Theory

Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year.

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Abracadabra I, II…HeartMate 3?

Form ever follows function

Victor van Berkel, MD, PhD

Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease Vincent Chan, MD, MPH, Marc Ruel, MD,

It is still mostly about the mitral valve

How should we treat air leaks?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Bicuspid aortic valve aortopathy: One size fits all?

A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Edward R

Long-term results of aortic valve–sparing operations in patients with Marfan syndrome Tirone E. David, MD, Sue Armstrong, BSc, Manjula Maganti, BSc, Jack.

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Intermediate-term results of repair for aortic, neoaortic, and truncal valve insufficiency in children John A. Hawkins, MD, Peter C. Kouretas, MD, PhD,

The variability of the mitral valve anatomy and terminology

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Structural deterioration of the Freestyle aortic valve: Mode of presentation and mechanisms Siamak Mohammadi, MD, Richard Baillot, MD, Pierre Voisine,

Military surgeons just want to have fun

Intermediate results of isolated mitral valve replacement with a Biocor porcine valve Giulio Rizzoli, MD, Tomaso Bottio, MD, PhD, Vladimiro Vida, MD,

Jules Lin, MD The Journal of Thoracic and Cardiovascular Surgery

Stephen R. Broderick, MD, MPHS

Get it right the first time

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Minimally invasive tricuspid valve surgery in patients at high risk

Replicating the success of mitral valve repair in the aortic valve

A fate worse than death Jennifer S. Lawton, MD

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

The Ross procedure: Outcomes at 20 years

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Functional tricuspid pathology: To treat or not to treat

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Long-term results of Freestyle stentless bioprosthesis in the aortic position: A single- center prospective cohort of 500 patients Nicolas Amabile, MD,

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

Aortic Carpentier-Edwards supraannular porcine bioprosthesis: a 12-year experience Yves Logeais, MD, Thierry Langanay, MD, Alain Leguerrier, MD, Claude.

The continuing challenge of congenital heart disease in China

Commentary: When a choice is not an echo

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Journal changes and initiatives

Presentation transcript:

Surgery for rheumatic tricuspid valve disease: A 30-year experience José M. Bernal, MD, Alejandro Pontón, MD, Begoña Diaz, MD, Javier Llorca, MD, Iván García, MD, Aurelio Sarralde, MD, Carmen Diago, MD, José M. Revuelta, MD The Journal of Thoracic and Cardiovascular Surgery Volume 136, Issue 2, Pages 476-481 (August 2008) DOI: 10.1016/j.jtcvs.2008.02.065 Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Actuarial survival curve for all causes of death (thin solid line) with 95% confidence interval (dashed lines). Thick solid line represents expected survival curve for cohort of Spanish population with same age and sex distribution. Number of patients at risk are displayed every 5 years. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 476-481DOI: (10.1016/j.jtcvs.2008.02.065) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Actuarial curve for freedom from reoperation (thick solid line) with 95% confidence interval (dashed lines). Number of patients at risk are displayed every 5 years. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 476-481DOI: (10.1016/j.jtcvs.2008.02.065) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions